KannaLife Sciences Inc.

Next-generation cannabinoid therapeutics for neurological disorders

Huntington, United States · Founded 2018 · $3.0M raised

Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$3.0M
Last Round
$1.5M GrantJan 2021
Rounds
2

About

KannaLife Sciences is a biopharmaceutical company and subsidiary of Neuropathix, Inc. focused on developing novel cannabinoid-based therapeutics targeting inflammation and neurological disorders. The company holds a license to the U.S. Government Patent 6,630,507 on cannabinoids as antioxidants and neuroprotectants, and has developed KLS-13019, a proprietary CBD-like molecule with significantly improved potency, bioavailability, and safety targeting conditions such as CTE, hepatic encephalopathy, and chemotherapy-induced neuropathy.

Summary

KannaLife Sciences Inc. is a Biotech company based in Huntington, United States, founded in 2018. It has raised $3.0M in total across 2 rounds, most recently a $1.5M Grant round in Jan 2021. Investors include The Michael J. Fox Foundation.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2021
$1.5M

Sign up to see all 2 rounds

Series A through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KannaLife Sciences Inc. on Indexed.vc
<a href="https://indexed.vc/companies/kannalife-sciences-inc"><img src="https://indexed.vc/api/badge/company/kannalife-sciences-inc" alt="KannaLife Sciences Inc. on Indexed.vc" width="260" height="76" /></a>